Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia
- PMID: 15193769
- DOI: 10.1016/j.neulet.2004.03.013
Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia
Abstract
We investigated the effects of prostaglandin E2 (PGE2) on amyloid precursor protein (APP) expression in cultured rat microglia. PGE2 treatment significantly increased the expression of APP holoprotein and was associated with an elevation in cyclic AMP (cAMP). Direct activation of adenylate cyclase with forskolin also increased APP expression. Co-treatment of microglia with PGE2 and the PKA inhibitor H-89 suppressed the overexpression of APP caused by PGE2 alone. The prostaglandin EP2 receptor is known to be positively coupled to cAMP production. Stimulation of the EP2 receptor with butaprost increased APP holoprotein, whereas co-incubation of the cells with PGE(2) and the EP2 receptor antagonist AH-6809 blocked the effect of PGE2 on APP expression. These data suggest that PGE2 is able to regulate the expression of APP, and that this effect may be mediated by the EP2 receptor and the cAMP signaling cascade.
Copyright 2004 Elsevier Ireland Ltd.
Similar articles
-
TNF-alpha/IFN-gamma-induced iNOS expression increased by prostaglandin E2 in rat primary astrocytes via EP2-evoked cAMP/PKA and intracellular calcium signaling.Glia. 2007 Jan 15;55(2):214-23. doi: 10.1002/glia.20453. Glia. 2007. PMID: 17091492
-
Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors.Glia. 1997 Feb;19(2):152-60. Glia. 1997. PMID: 9034831
-
EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures.Bone. 2009 Jun;44(6):1177-85. doi: 10.1016/j.bone.2009.02.010. Epub 2009 Feb 21. Bone. 2009. PMID: 19233324
-
The Double Roles of the Prostaglandin E2 EP2 Receptor in Intracerebral Hemorrhage.Curr Drug Targets. 2017;18(12):1377-1385. doi: 10.2174/1389450117666151209122826. Curr Drug Targets. 2017. PMID: 26648067 Review.
-
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons.Brain Pathol. 2005 Apr;15(2):134-8. doi: 10.1111/j.1750-3639.2005.tb00509.x. Brain Pathol. 2005. PMID: 15912885 Free PMC article. Review.
Cited by
-
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Biochem Pharmacol. 2014 Apr 15;88(4):565-72. doi: 10.1016/j.bcp.2013.12.014. Epub 2014 Jan 13. Biochem Pharmacol. 2014. PMID: 24434190 Free PMC article. Review.
-
Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.J Neurosci. 2005 Sep 7;25(36):8240-9. doi: 10.1523/JNEUROSCI.1808-05.2005. J Neurosci. 2005. PMID: 16148231 Free PMC article.
-
Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.Metab Brain Dis. 2018 Aug;33(4):1141-1153. doi: 10.1007/s11011-018-0206-6. Epub 2018 Mar 22. Metab Brain Dis. 2018. PMID: 29569150
-
The role of inflammatory processes in Alzheimer's disease.Inflammopharmacology. 2012 Jun;20(3):109-26. doi: 10.1007/s10787-012-0130-z. Epub 2012 Apr 26. Inflammopharmacology. 2012. PMID: 22535513 Review.
-
Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice.J Neurosci. 2008 Apr 30;28(18):4785-94. doi: 10.1523/JNEUROSCI.0684-08.2008. J Neurosci. 2008. PMID: 18448655 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources